Agios Pharmaceuticals | AGIO - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
AbbVie USD 12.48B 110M 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Arrowhead Research USD 8.56M 7.13M 2026-06
Astellas Pharma JPY 844.8B 83.04B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bayer EUR 18.7B 146M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Exelixis USD 322.21M 6.73M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Merck USD 12.21B 435M 2026-03
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.19B 19M 2026-06
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06